NovoCure (NVCR) Short Interest Ratio & Short Volume → Your $200 account credit is about to expire (From MarketBeat) (Ad) Free NVCR Stock Alerts $22.32 -0.83 (-3.59%) (As of 05/28/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends NovoCure Short Interest DataCurrent Short Interest5,640,000 sharesPrevious Short Interest5,640,000 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$118.72 millionShort Interest Ratio4.1 Days to CoverLast Record DateMay 15, 2024Outstanding Shares107,610,000 sharesFloat Size96,890,000 sharesShort Percent of Float5.82%Today's Trading Volume1,537,452 sharesAverage Trading Volume1,357,024 sharesToday's Volume Vs. Average113% Short Selling NovoCure ? Sign up to receive the latest short interest report for NovoCure and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNVCR Short Interest Over TimeNVCR Days to Cover Over TimeNVCR Percentage of Float Shorted Over Time Ad Resource Stock DigestDigitizing the $11T commodities sector with one tiny stockOne tiny company — trading completely undiscovered around 15-cents per share — has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. It’s an opportunity that likely won’t stay at these levels for long NovoCure Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20245,640,000 shares $118.72 million No Change5.8%4.1 $21.05 4/30/20245,640,000 shares $69.03 million -6.6%5.8%4.4 $12.24 4/15/20246,040,000 shares $76.83 million +20.6%6.3%4.8 $12.72 3/31/20245,010,000 shares $78.31 million -9.6%5.2%3.6 $15.63 3/15/20245,540,000 shares $77.45 million -1.8%5.8%4.5 $13.98 2/29/20245,640,000 shares $86.35 million -8.0%5.9%4.4 $15.31 Get the Latest News and Ratings for NVCR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NovoCure and its competitors with MarketBeat's FREE daily newsletter. 2/15/20246,130,000 shares $97.65 million +6.2%6.3%4.6 $15.93 1/31/20245,770,000 shares $80.32 million -17.0%6.0%4.2 $13.92 1/15/20246,950,000 shares $93.06 million +0.3%7.2%4.8 $13.39 12/31/20236,930,000 shares $103.46 million -2.8%7.2%5 $14.93 12/15/20237,130,000 shares $96.68 million -10.5%7.4%5 $13.56 11/30/20237,970,000 shares $97.79 million -5.0%8.3%5.5 $12.27 11/15/20238,390,000 shares $106.39 million -6.1%8.7%4.5 $12.68 10/31/20238,930,000 shares $118.77 million +6.3%9.2%4.8 $13.30 10/15/20238,400,000 shares $119.36 million +2.8%8.7%4.5 $14.21 9/30/20238,170,000 shares $131.95 million +7.8%8.5%4.2 $16.15 9/15/20237,580,000 shares $146.29 million -17.7%7.9%4.3 $19.30 8/31/20239,210,000 shares $203.17 million -1.8%9.6%5 $22.06 8/15/20239,380,000 shares $293.59 million +5.9%9.7%5.7 $31.30 7/31/20238,860,000 shares $289.19 million -0.2%N/A5.7 $32.64 7/15/20238,880,000 shares $354.67 million +2.0%N/A6.4 $39.94 6/30/20238,710,000 shares $361.47 million +3.7%N/A6.9 $41.50 6/15/20238,400,000 shares $368.76 million +4.0%N/A6.9 $43.90 5/31/20238,080,000 shares $580.22 million -1.2%N/A7.5 $71.81 5/15/20238,180,000 shares $636.57 million +5.8%N/A12.4 $77.82 4/30/20237,730,000 shares $509.41 million -1.9%N/A12.1 $65.90 4/15/20237,880,000 shares $494.23 million +2.1%7.6%12 $62.72 3/31/20237,720,000 shares $464.28 million -3.3%7.5%9.5 $60.14 3/15/20237,980,000 shares $523.17 million -8.4%7.7%7.8 $65.56 2/28/20238,710,000 shares $670.41 million +3.4%N/A9 $76.97 2/15/20238,420,000 shares $740.71 million +4.5%8.2%8.8 $87.97 1/31/20238,060,000 shares $734.91 million +3.9%7.8%8.5 $91.18 1/15/20237,760,000 shares $729.36 million -2.4%7.5%8.4 $93.99 12/30/20227,950,000 shares $583.13 million +2.3%7.7%9.4 $73.35 12/15/20227,770,000 shares $579.56 million -4.0%7.5%14.8 $74.59 11/30/20228,090,000 shares $621.64 million -1.3%7.9%16.6 $76.84 11/15/20228,200,000 shares $688.80 million -1.2%8.0%17.6 $84.00 10/31/20228,300,000 shares $586.48 million +4.3%8.1%18.2 $70.66 10/15/20227,960,000 shares $582.11 million +5.4%7.7%16.5 $73.13 9/30/20227,550,000 shares $573.65 million +0.3%7.3%16.7 $75.98Digitizing the $11T commodities sector with one tiny stock (Ad)One tiny company — trading completely undiscovered around 15-cents per share — has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. It’s an opportunity that likely won’t stay at these levels for long 9/15/20227,530,000 shares $669.79 million +2.9%7.3%16 $88.95 8/31/20227,320,000 shares $601.19 million +5.5%7.1%12.9 $82.13 8/15/20226,940,000 shares $585.18 million +2.4%6.8%11.3 $84.32 7/31/20226,780,000 shares $460.97 million -1.2%6.6%10.1 $67.99 7/15/20226,860,000 shares $497.08 million +1.8%7.3%10.4 $72.46 6/30/20226,740,000 shares $468.43 million -11.1%7.5%10 $69.50 6/15/20227,580,000 shares $461.17 million -6.8%8.4%11.3 $60.84 5/31/20228,130,000 shares $653.49 million -0.3%9.0%13.5 $80.38 5/15/20228,150,000 shares $531.71 million +4.5%9.0%14 $65.24 4/30/20227,800,000 shares $597.32 million +5.1%8.7%13.2 $76.58 4/15/20227,420,000 shares $625.06 million -0.7%8.3%12.1 $84.24 3/31/20227,470,000 shares $618.89 million +2.8%8.3%10.9 $82.85 3/15/20227,270,000 shares $471.90 million +1.4%8.1%10 $64.91 2/28/20227,170,000 shares $586.94 million +0.1%8.0%10.1 $81.86 2/15/20227,160,000 shares $604.30 million +8.5%8.0%9.6 $84.40 1/31/20226,600,000 shares $453.09 million +5.1%7.4%8.7 $68.65 1/15/20226,280,000 shares $434.07 million +8.3%7.1%8.5 $69.12 12/31/20215,800,000 shares $435.46 million No Change6.5%8.9 $75.08 12/15/20215,800,000 shares $487.84 million -4.5%6.5%9.8 $84.11 11/30/20216,070,000 shares $568.39 million +5.8%6.8%10.7 $93.64 11/15/20215,740,000 shares $645.29 million +7.9%6.4%11.1 $112.42 10/29/20215,320,000 shares $545.67 million -0.4%6.0%11.9 $102.57 10/15/20215,340,000 shares $599.25 million -1.7%6.0%10.2 $112.22 9/30/20215,430,000 shares $630.80 million +0.7%6.1%10.4 $116.17 9/15/20215,390,000 shares $683.61 million -0.2%6.1%9 $126.83 8/31/20215,400,000 shares $724.73 million +0.6%6.1%8.2 $134.21 8/13/20215,370,000 shares $747.93 million +2.9%6.0%7.9 $139.28 7/30/20215,220,000 shares $803.93 million +2.4%5.9%7.2 $154.01 7/15/20215,100,000 shares $930.70 million +0.2%5.8%7.4 $182.49 6/30/20215,090,000 shares $1.13 billion -5.4%5.7%4.8 $221.82 6/15/20215,380,000 shares $1.17 billion +5.9%6.1%5.4 $216.79 5/28/20215,080,000 shares $1.04 billion +2.2%5.7%5.2 $204.00 5/14/20214,970,000 shares $860.01 million +2.1%5.6%4.6 $173.04 4/30/20214,870,000 shares $999.86 million +0.4%5.5%4.5 $205.31 4/15/20214,850,000 shares $902.10 million +2.5%5.5%4.7 $186.00 3/31/20214,730,000 shares $592.43 million +6.8%5.4%6.7 $125.25 3/15/20214,430,000 shares $612.62 million -3.9%5.1%5.7 $138.29 2/26/20214,610,000 shares $686.43 million -0.7%5.3%5.1 $148.90 2/12/20214,640,000 shares $849.49 million -5.3%5.3%4.9 $183.08 1/29/20214,900,000 shares $790.37 million -6.5%5.6%5 $161.30 1/15/20215,240,000 shares $937.65 million -2.4%6.1%4.9 $178.94 12/31/20205,370,000 shares $935.13 million -8.7%6.2%4.6 $174.14 12/15/20205,880,000 shares $993.66 million +17.8%6.8%5 $168.99 11/30/20204,990,000 shares $632.93 million -2.9%5.9%3.8 $126.84 11/15/20205,140,000 shares $639.83 million +25.1%6.1%4.5 $124.48 10/30/20204,110,000 shares $506.64 million -11.8%4.9%3.8 $123.27 10/15/20204,660,000 shares $637.58 million -12.6%5.6%4.7 $136.82 9/30/20205,330,000 shares $593.28 million +41.4%6.4%5.5 $111.31 9/15/20203,770,000 shares $393.81 million +14.6%4.5%3.4 $104.46 8/31/20203,290,000 shares $272.25 million +6.5%3.9%3.5 $82.75Digitizing the $11T commodities sector with one tiny stock (Ad)One tiny company — trading completely undiscovered around 15-cents per share — has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. It’s an opportunity that likely won’t stay at these levels for long 8/14/20203,090,000 shares $233.88 million +0.3%3.7%3.3 $75.69 7/31/20203,080,000 shares $233.43 million -2.2%3.7%3.1 $75.79 7/15/20203,150,000 shares $200.47 million -6.8%3.8%3.1 $63.64 6/30/20203,380,000 shares $200.43 million -17.0%4.1%3.4 $59.30 6/15/20204,070,000 shares $265.85 million +9.1%4.9%4.6 $65.32 5/29/20203,730,000 shares $251.51 million -5.6%4.5%3.9 $67.43 5/15/20203,950,000 shares $255.41 million No Change4.8%3.9 $64.66 4/30/20203,950,000 shares $259.91 million -2.2%4.8%4 $65.80 4/15/20204,040,000 shares $282.72 million +3.1%4.9%4.4 $69.98 3/31/20203,920,000 shares $286.87 million -2.2%4.8%3.9 $73.18 3/13/20204,008,800 shares $280.62 million +3.6%5.5%3.4 $70.00 2/28/20203,870,000 shares $220.78 million -0.8%5.3%4.2 $57.05 2/14/20203,900,000 shares $286.07 million -1.3%4.9%4.5 $73.35 1/31/20203,950,000 shares $313.87 million -3.9%5.0%4.6 $79.46 1/15/20204,110,000 shares $372.57 million +5.4%5.2%4.5 $90.65 12/31/20193,900,000 shares $340.43 million +4.0%4.9%4.9 $87.29 8/15/20195,283,500 shares $497.02 million +7.4%7.2%7 $94.07 NVCR Short Interest - Frequently Asked Questions What is NovoCure's current short interest? Short interest is the volume of NovoCure shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 5,640,000 shares of NVCR short. 5.82% of NovoCure's shares are currently sold short. Learn More on NovoCure's current short interest. What is a good short interest ratio for NovoCure? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NVCR shares currently have a short interest ratio of 4.0. Learn More on NovoCure's short interest ratio. Which institutional investors are shorting NovoCure? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of NovoCure: Walleye Trading LLC, Jane Street Group LLC, HAP Trading LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for NovoCure? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.82% of NovoCure's floating shares are currently sold short. What is NovoCure's float size? NovoCure currently has issued a total of 107,610,000 shares. Some of NovoCure's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. NovoCure currently has a public float of 96,890,000 shares. How does NovoCure's short interest compare to its competitors? 5.82% of NovoCure's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to NovoCure: ICU Medical, Inc. (5.42%), Inari Medical, Inc. (9.79%), Integra LifeSciences Holdings Co. (3.77%), iRhythm Technologies, Inc. (9.84%), LeMaitre Vascular, Inc. (4.21%), Tandem Diabetes Care, Inc. (14.01%), Alphatec Holdings, Inc. (8.11%), Axonics, Inc. (7.04%), PROCEPT BioRobotics Co. (9.79%), MiMedx Group, Inc. (3.98%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short NovoCure stock? Short selling NVCR is an investing strategy that aims to generate trading profit from NovoCure as its price is falling. NVCR shares are trading down $1.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against NovoCure? A short squeeze for NovoCure occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NVCR, which in turn drives the price of the stock up even further. How often is NovoCure's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NVCR, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: ICUI Short Interest Data NARI Short Interest Data IART Short Interest Data IRTC Short Interest Data LMAT Short Interest Data TNDM Short Interest Data ATEC Short Interest Data AXNX Short Interest Data PRCT Short Interest Data MDXG Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NVCR) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersWARNING about the death of the U.S. dollar…Colonial MetalsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersDigitizing the $11T commodities sector with one tiny stockResource Stock DigestBiggest Prediction of My 50-Year Career on Wall StreetChaikin AnalyticsHe Is Giving Away BitcoinCrypto Swap ProfitsTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy SykesTruth about Trump you’ve never heardPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NovoCure Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.